Terms: = Liver cancer AND ARID1B, 6A3-5, 57492, ENSG00000049618, p250R, KIAA1235, ELD/OSA1, DAN15, BRIGHT, BAF250b AND Staging
3 results:
1. Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients.
Mazzola G; Adamoli L; Calvaruso V; Macaluso FS; Colletti P; Mazzola S; Cervo A; Trizzino M; Di Lorenzo F; Iaria C; Prestileo T; Orlando A; Di Marco V; Cascio A
Infection; 2019 Jun; 47(3):409-415. PubMed ID: 30519966
[TBL] [Abstract] [Full Text] [Related]
2. Imaging of primary and metastatic pancreatic cancer using a fluorophore-conjugated anti-CA19-9 antibody for surgical navigation.
McElroy M; Kaushal S; Luiken GA; Talamini MA; Moossa AR; Hoffman RM; Bouvet M
World J Surg; 2008 Jun; 32(6):1057-66. PubMed ID: 18264829
[TBL] [Abstract] [Full Text] [Related]
3. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.
Zech CJ; Herrmann KA; Reiser MF; Schoenberg SO
Magn Reson Med Sci; 2007; 6(1):43-52. PubMed ID: 17510541
[TBL] [Abstract] [Full Text] [Related]
